Alaunos Therapeutics (TCRT) Stock Chart & Stock Price History $2.46 +0.07 (+2.71%) As of 09:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alaunos Therapeutics Stock Price Performance The Alaunos Therapeutics (TCRT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 4.89%, with a year-to-date return of 29.74%. In the past month, the stock has decreased 27.07%, reflecting recent market activity. As of the latest close, Alaunos Therapeutics traded at $2.40 with a market cap of $3.94 million and volume of 23,712 shares. Receive TCRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.20%1 Month Performance-27.07%3 Month Performance-12.59%Year-To-Date Performance+29.74%1 Year Performance+4.89% TCRT Stock Chart for Friday, August, 15, 2025 TCRT Chart by TradingView Alaunos Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$2.39$2.40+0.42%$2.54$2.3923,712 shs$3.94 million08/13/2025$2.44$2.39-2.05%$2.53$2.1653,063 shs$3.92 million08/12/2025$2.54$2.44-3.94%$2.74$2.3934,626 shs$4.00 million08/11/2025$2.47$2.54+2.83%$2.85$2.4462,967 shs$4.17 million08/08/2025$2.60$2.47-5.00%$2.79$2.4388,023 shs$4.05 million08/07/2025$2.84$2.60-8.45%$2.81$2.5824,274 shs$4.26 million08/06/2025$2.94$2.84-3.40%$3.00$2.8275,281 shs$4.66 million08/05/2025$3.02$2.94-2.65%$3.15$2.8090,824 shs$4.82 million08/04/2025$2.74$3.02+10.22%$3.02$2.6028,805 shs$4.95 million08/01/2025$2.85$2.74-3.86%$2.84$2.587,272 shs$4.49 million Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$2.87$2.85-0.70%$3.00$2.8319,981 shs$4.67 million07/30/2025$2.77$2.87+3.61%$3.13$2.7244,983 shs$4.71 million07/29/2025$3.00$2.77-7.67%$3.14$2.6939,177 shs$4.54 million07/28/2025$2.81$3.00+6.76%$3.15$2.9529,596 shs$4.92 million07/25/2025$2.98$2.81-5.70%$2.97$2.5047,143 shs$4.61 million07/24/2025$3.10$2.98-3.87%$3.22$2.9520,653 shs$4.89 million07/23/2025$2.99$3.10+3.68%$3.14$2.8251,250 shs$5.08 million07/22/2025$3.10$2.99-3.55%$3.26$2.9954,411 shs$4.90 million07/21/2025$3.24$3.10-4.32%$3.38$3.0877,487 shs$5.08 million07/18/2025$3.26$3.24-0.61%$3.57$3.1089,018 shs$5.31 million07/17/2025$3.25$3.26+0.31%$3.94$3.2350,109 shs$5.35 million07/16/2025$3.38$3.25-3.85%$3.64$3.2341,316 shs$5.33 million07/15/2025$4.00$3.38-15.50%$4.00$3.3588,451 shs$5.54 million07/14/2025$4.99$4.00-19.84%$6.20$3.97375,351 shs$6.56 million Related Companies Relmada Therapeutics Stock Price Chart NeuroSense Therapeutics Stock Price Chart Chemomab Therapeutics Stock Price Chart Hoth Therapeutics Stock Price Chart Passage Bio Stock Price Chart BioXcel Therapeutics Stock Price Chart Aspire Biopharma Stock Price Chart Lexaria Bioscience Stock Price Chart Abpro Stock Price Chart BioLineRx Stock Price Chart Receive TCRT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access